Scientists have used artificial intelligence (AI) to create potential new drugs for so-called superbugs – stubborn bacterial infections that can evade existing treatments.

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.

Highmark Health is rolling out Abridge's AI medical scribe and plans to codesign an AI-powered prior auth tool at the point of care.

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients' use of medications that may be unnecessary or even harmful to them.

Anthropic says it has revoked OpenAI's access to the Claude API after ChatGPT's engineers were found using Claude's coding tools.

Want to Develop Greater Willpower and Determination? A New Study Shows How to Use the Navy SEAL 40 Percent Rule Science says staying the course—a key ingredient for success—comes down to ...

Erin Ggaadimits Ivalu Gingrich will earn a cash award and have works on display in the Eiteljorg Museum of American Indians and Western Art in Indianapolis from November 2025 to February 2026.

Business Scientists develop game-changing method to make use of coffee waste: 'This is a true circular economy solution' "We've taken what was once waste and upcycled it into value." ...

Many Iranians tell Newsweek they are uniting to help one another with shared resources and support as conflict with Israel escalates ...

These findings may help researchers to better understand addiction in humans and accelerate the creation of new therapies for cocaine use disorder (CUD), according to a related press release.

The Trump administration is developing a plan to use Cold War-era powers to prioritize and fund rare earth projects it deems critical to national security, people familiar with the matter said.